What is the recommended treatment for a leprosy (Hansen’s disease) flare, including management of type‑1 reversal reactions and type‑2 erythema nodosum leprosum?

Treatment of Hansen's Disease (Leprosy) Flares

Immediate Assessment and Classification

The first priority when managing a leprosy flare is to determine whether the patient is experiencing a Type 1 reversal reaction or Type 2 erythema nodosum leprosum (ENL), as treatment differs substantially between these two immunologic reactions. 1, 2, 3

Type 1 Reversal Reaction Recognition

• Look for swelling of existing skin lesions and nerve trunks, often occurring soon after starting antimicrobial therapy 1, 3
• Assess for new-onset neuritis with acute nerve tenderness, weakness, or sensory loss 2, 3
• This reaction occurs predominantly in borderline or tuberculoid (paucibacillary) leprosy patients 1, 4
• The mechanism involves enhanced delayed hypersensitivity to residual M. leprae antigens as bacterial load decreases 1, 4

Type 2 Erythema Nodosum Leprosum Recognition

• Identify fever with tender erythematous skin nodules that may become pustular or ulcerate 1, 3
• Check for systemic manifestations: malaise, neuritis, orchitis, albuminuria, joint swelling, iritis, epistaxis, or depression 1, 2
• This reaction occurs mainly in lepromatous (multibacillary) patients, affecting approximately 50% in the first year of treatment 1, 4
• The pathophysiology involves vasculitis with polymorphonuclear infiltrate driven by elevated circulating immune complexes 1, 4

Continue Antimicrobial Therapy During Reactions

In general, anti-leprosy multidrug therapy should be continued during both Type 1 and Type 2 reactions unless there are specific contraindications. 1, 2, 3

• Stopping antimicrobial treatment does not improve the reaction and may allow disease progression 2, 5
• The reactions represent immunologic responses to bacterial antigens, not treatment failure 3, 4

Treatment Algorithm for Type 1 Reversal Reactions

Mild Reversal Reaction (No Neuritis)

• Administer analgesics for symptomatic relief 1, 2
• Monitor closely for development of nerve involvement 3
• Continue standard multidrug antimicrobial therapy 1, 2

Severe Reversal Reaction or Any Neuritis Present

If the reversal reaction is severe or if any neuritis is present, large doses of corticosteroids should always be used. 1, 3

• Hospitalize the patient if the reaction is severe 1, 3
• Initiate prednisone at high doses (typically 40-60 mg daily, though specific dosing is not standardized) 3, 5
• Taper corticosteroids slowly over weeks to months based on clinical response 2, 3
• Consider surgical decompression of swollen nerve trunks if medical management fails 1, 2
• Contact the National Hansen's Disease Program (USPHS at Carville, LA) for management guidance 1

Reversal reactions are the most common cause of permanent nerve damage in leprosy, making prompt corticosteroid treatment essential to prevent disability. 3

Treatment Algorithm for Type 2 Erythema Nodosum Leprosum

Mild ENL

• Use analgesics for symptomatic pain control 1, 2
• Continue multidrug antimicrobial therapy 1, 2
• Monitor for progression to severe disease 3

Severe ENL

If ENL is severe, the patient should be hospitalized. 1, 3

First-Line Treatment Options

• Thalidomide is the preferred agent for ENL when available and not contraindicated (particularly effective for this reaction type) 2, 3
• Prednisone (corticosteroids) as an alternative or adjunct to thalidomide 1, 3
• Analgesics for symptomatic relief 1, 2

Additional Treatment Options for Refractory ENL

• Pentoxifylline may be considered 2
• Tumor necrosis factor inhibitors have been used in refractory cases 2
• T cell inhibitors are investigational options 2
• Clofazimine (available only as an investigational drug through the National Hansen's Disease Program) 2, 5

Contact the National Hansen's Disease Program (USPHS, Carville, LA) to obtain thalidomide, clofazimine, or other specialized agents for ENL management. 1, 2

Critical Pitfalls and Caveats

Timing of Reactions

• Leprosy reactions may occur before, during, or after antimicrobial treatment, not just during active therapy 2, 3
• Approximately 50% of lepromatous patients experience ENL in the first year of treatment 1
• Reversal reactions often occur soon after starting chemotherapy 1, 3

Nerve Damage Prevention

• Reversal reactions cause the majority of permanent nerve damage in leprosy—any suspicion of neuritis demands immediate high-dose corticosteroid therapy 3
• ENL may also lead to neuritis requiring urgent treatment 3
• Delayed treatment of neuritis results in irreversible disability 2, 3

Thalidomide Contraindications

• Thalidomide is absolutely contraindicated in pregnancy due to severe teratogenicity 2, 3
• Strict pregnancy prevention measures are mandatory for women of childbearing potential 2
• Thalidomide availability is restricted and requires special authorization 1, 2

Distinguishing Reaction Types

• Type 1 reactions show swelling of existing lesions with cell-mediated immune enhancement 1, 4
• Type 2 reactions present with new nodular lesions and systemic symptoms from immune complex deposition 1, 4
• Histopathology differs: Type 1 shows granulomatous inflammation; Type 2 shows vasculitis with neutrophils 4

Lucio Phenomenon

• A rare variant (sometimes classified as Type 3 reaction) presents with hemorrhagic skin infarcts 4
• Requires corticosteroid treatment similar to reversal reactions 3, 4
• Associated with high mortality if untreated 4

Consultation and Resources

Contact the National Hansen's Disease Program for expert guidance on complex cases, access to specialized medications (thalidomide, clofazimine), and management recommendations. 1, 2, 5

• The program provides medical care, research support, and clinical information for Hansen's disease 5
• Specialized agents for reaction management are available only through this program 1, 2